
|Videos|July 27, 2022
Dr. Alexis Rompré-Brodeur on germline testing in renal cell carcinoma
Author(s)Urology Times staff
Advertisement
Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study to assess adaptive-dosed 177Lu-DOTA-HYNIC-panPSMA in mHSPC
2
Practical tips for AE management with the gemcitabine intravesical system
3
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
4
Department of Defense announces annual testosterone deficiency screening for service members
5













